NIH-funded research R01 grant

Stopping fat-driven cell damage to protect metabolic health

Official title: Lipotoxicity and Maintenance of Metabolic Health

Funded at Joslin Diabetes Center · NIH-11324243 · Data updated 2026-11-12

Testing whether removing certain tiny RNAs inside cells can prevent fat-related liver and metabolic damage in adults with type 2 diabetes.

More Metabolic Health research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJoslin Diabetes Center
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 1, 2023
Project endApril 30, 2027
Funding year2026
Award (this year)$597,775
NIH project number5R01DK137511-04
Project IDNIH-11324243 on NIH RePORTER

Who could benefit from this research

Could help

Adults with type 2 diabetes or non-alcoholic fatty liver disease would be the most likely future candidates for therapies inspired by this research, although the current work is performed in labs and animal models.

Less likely to help

People without metabolic disease, children, or anyone seeking immediate treatment are unlikely to receive direct benefit from this preclinical grant.

What this research studies

Researchers will study a group of small nucleolar RNAs (snoRNAs) that appear to make cells more vulnerable to damage from excess fat. They will remove these snoRNAs in cell experiments and in mice fed high-fat diets to see whether tissues such as the liver are protected from lipotoxic injury. The team will link snoRNA levels to changes in how proteins are made by ribosomes and how dietary fats influence those processes. Results could point to new molecular targets for treating fatty liver and other complications of type 2 diabetes.

Why it matters

Potential benefit: If successful, this work could reveal new targets for drugs that prevent or treat non-alcoholic fatty liver disease and other fat-overload complications of diabetes.

How similar studies have gone: Basic studies have linked snoRNAs and ribosome modifications to cellular stress, but using snoRNA knockout to protect against diet-induced fatty liver is a relatively new approach.

Where this research is happening

  • Joslin Diabetes Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Schaffer, Jean E. — Joslin Diabetes Center
  • Study coordinator: Schaffer, Jean E.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.